Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000433823 | SCV000532666 | likely benign | not specified | 2016-12-22 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001248135 | SCV001421602 | likely benign | Duchenne muscular dystrophy | 2024-04-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002446738 | SCV002735234 | likely benign | Cardiovascular phenotype | 2020-06-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV003144264 | SCV003834740 | uncertain significance | not provided | 2021-07-22 | criteria provided, single submitter | clinical testing |